If you have any questions about Entyvio and its role in the management of ulcerative colitis or Crohn's disease, please use the details given here to contact Takeda UK.
Fields marked with an asterisk (*) are required fields.
Adverse events should be reported. In the United Kingdom, reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Takeda by e-mail at DSO-UK@takeda.com